LitAlert ~~ GeneLit.com

    • Breast cancer survival in Nordic BRCA2 mutation carriers—unconventional association with oestrogen receptor status.
    • Olafsdottir EJ, Borg A, Jensen MB, Gerdes AM, Johansson ALV, Barkardottir RB, Johannsson OT, Ejlertsen B, Heeholm Sønderstrup IM, Hovig E, Lænkholm AV, van Overeem Hansen T, Olafsdottir GH, Rossing M, Jonasson JG, Sigurdsson S, Loman N, Nilsson MP, Narod SA, Tryggvadottir L.
    • Br J Cancer. 2020 Sep 17. doi: 10.1038/s41416-020-01056-4. [Epub ahead of print]
    • A shared genetic contribution to breast cancer and schizophrenia.
    • Lu D, Song J, Lu Y, Fall K, Chen X, Fang F, Landén M, Hultman CM, Czene K, Sullivan P, Tamimi RM, Valdimarsdóttir UA.
    • Nat Commun. 2020 Sep 15;11(1):4637. doi: 10.1038/s41467-020-18492-8.
    • Male Breast Cancer in Togo: Imaging and Clinicopathological Findings.
    • Darre T, Tchaou M, Djiwa T, Simgban P, Amavi AK, N'Timon B, Amadou A, Bombonne M, Sama B, Amégbor K, Napo-Koura G.
    • Int J Breast Cancer. 2020 Aug 31;2020:3056067. doi: 10.1155/2020/3056067.
    • Hormone therapy after risk-reducing surgery in patients with BRCA1/BRCA2 mutation: evaluation of potential benefits and safety.
    • Silva Filho ALD, Carvalho GM, Sena LC, Gomes LPG, Valério MFH, Martins RIL, Cândido EB.
    • Rev Assoc Med Bras (1992). 2020 Aug;66(8):1134-1138. doi: 10.1590/1806-9282.66.8.1134.